tumor

November 19, 2024
Posted by Communication - IIS Aragón el November 19, 2024
Categories

Dolores Isla, IP of the IIS Aragón: “Spain is a leader in participation in clinical trials for lung cancer”

On the occasion of World Lung Cancer Day, ConSalud.es interviews Dr. Dolores Isla, IP of the Medical Oncology group at the Lozano Blesa Clinical Hospital (GIIS025) of the IIS Aragón and president of the Association for Lung Cancer Research in Women.
Do you like it?
Read more
September 17, 2024
Posted by Communication - IIS Aragón el September 17, 2024
Categories

On the trail of new biomarkers to detect glioblastoma and colorectal cancer

A new study by the IIS Aragón and the Aragón Engineering Research Institute, published by the Scientific Society of Biofabrication, recreates tumors in 3D models and analytical chemistry techniques to open new, less invasive diagnostic pathways that improve patient prognosis.
Do you like it?
Read more
11 June, 2024
Posted by Communication - IIS Aragón el 11 June, 2024
Categories

More than 500 patients have already undergone the Servet prostate cancer genetic counseling service

Ángel Borque is the section head of the Prostate Unit of the Servet Urology service and leads a study at the Aragón Health Research Institute (IIS Aragón) for the use of artificial intelligence for the diagnosis of prostate cancer.
Do you like it?
Read more
November 27, 2023
Posted by Communication - IIS Aragón el November 27, 2023
Categories

A treatment that attacks two proteins at the same time opens the door to controlling the worst breast cancer

A new study has shown that the simultaneous inhibition of two different proteins may represent an effective new strategy to combat triple-negative breast cancer.
Do you like it?
Read more